The University of Auckland
About The University of Auckland
The University of Auckland (Māori: Te Whare Wānanga o Tāmaki Makaurau) is the largest university in New Zealand, located in the country's largest city, Auckland. It is the highest-ranked university in the country, being ranked 82nd worldwide in the 2015/16 QS World University Rankings. Established in 1883 as a constituent college of the University of New Zealand, the university is made up of eight faculties over six campuses. It has a head count of more than 40,000 students, and more than 30,000 equivalent full-time students.
15th in the world
9th in the world
9th in the world
3rd in New Zealand
Journal Editors at The University of Auckland
Reviewers from The University of Auckland
My research investigates the relationship of assessment qualities and purposes on student and teacher responses to assessment including learning outcomes across a variety of cultural and social contexts. My research has shown that teacher and student beliefs are (1) contingent on assessment quality, (2) consistent with cultural values and priorities, and (3) play a significant part in explaining adaptive and maladaptive outcomes. Further, my research has shown that improvement is best achieved through high-quality assessment practices and systems that provide rich feedback to both test-users and test-takers and that this outcome is contingent on ensuring low-stakes consequences are attached to assessments.
Professor Nathan Consedine, Ph.D. is a health psychologist in the School of Medicine at the University of Auckland. His training is in emotion and emotion regulation looking at how such factors may be linked to physical health including screening, symptoms, adherence, and adaptation to chronic disease. Current research foci include disgust in health contexts, mindfulness, and physician compassion.
After graduating from Canterbury in 2000 and spending 10 years working on grants in New York, Nathan returned to New Zealand in 2009 as an Associate Professor in Psychological Medicine. In addition to teaching in the medical program, he supervises numerous PhD students conducting RCTs among arthritis, cancer, and diabetes patients as well as clinician researchers examining how patient, physician, clinical and environmental factors impact medical compassion.
Nathan has published more than 130 scientific works and is an Associate Editor and reviewer for numerous international journals. He enjoys fishing, tennis, playing with his young son, and listening to the sort of music that his colleagues dislike.
Professor Andrew Jull is a Registered Nurse and clinical epidemiologist with broad research interests in wounds, obesity prevention, weight management, and a variety of clinical issues. Formerly Co-Editor Evidence Based Nursing (2002-2009) and Handling Editor International Journal of Nursing Studies (2010-2014).
Dr José Derraik was born in Rio de Janeiro (Brazil), but moved to New Zealand in 1995. José has a very broad academic background, with a BSc and MSc in Ecology from the University of Otago (New Zealand), and a PhD in Public Health (University of Otago). His MSc examined invertebrate biodiversity in human-modified habitats. His PhD focused on vector ecology, more precisely on mosquitoes in New Zealand and how the threat of a mosquito-borne disease outbreak has been affected by ongoing anthropogenic environmental change. José then worked as a Senior Advisor for MAF Biosecurity NZ, where he provided expert advice to the NZ government on biosecurity threats to human health.
In 2008, José joined the Liggins Institute (University of Auckland) where he has been working on paediatric research, as well as on a number of clinical trials in adolescents and adults at risk of metabolic disease. His research focuses primarily on the long-term effects of early life events (such as preterm or post-term birth) in childhood. However, José has recently been appointed as an honorary research associate at Uppsala University in Sweden, where alongside his Swedish colleagues he has been examining also the long-term effects of early life events in adulthood.
Lastly, José is currently involved in a large multi-institutional project (A Better Start) in New Zealand, with a leading role in a number of studies aiming to predict, prevent, and mitigate childhood obesity in the country.
Dr Rupenthal is currently a Senior Lecturer in the Department of Ophthalmology and the Director of the Buchanan Ocular Therapeutics Unit, which aims to develop and translate ocular therapeutic related scientific research into the clinical setting. Ilva received a BPharm from the Philipps-University of Marburg, Germany, in 2003 and completed a PhD on ‘Ocular delivery of antisense oligonucleotides’ with the School of Pharmacy and the Department of Ophthalmology, University of Auckland, in 2008. In 2010, Ilva was awarded a prestigious three-year New Zealand Science and Technology Postdoctoral Fellowship to establish an ocular pharmaceutics group within the New Zealand National Eye Centre. In 2013, she then received a prestigious $500,000 HRC Sir Charles Hercus Research Fellowship to continue her innovative research into stimuli-responsive ocular implants. Dr Rupenthal has received several awards including the 2016 HRC Celebrating Research Excellence Award and the 2014 University of Auckland Early Career Research Excellence Award, while also being a winner of the Spark Entrepreneurship Ideas Challenges in 2012 and 2014.